Brought to you by:
Bad reading: How to claw back negative revenue?
Five frequently performed vascular surgeries at a prominent New Orleans-based health system between 2019 and 2022 yielded an average yearly decrease in net revenue of -11.5%, lending weight to growing national evidence that lay bare how increasing direct costs are…
Study hints at long-term cost-effectiveness of CDT and PMT over oral anticoagulation for moderate and severe PTS
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, MD, a clinical research fellow for vascular surgery at Imperial College London in London, England, presented findings from a study on the…
VAM abstract submissions hit near-historic high
A nearly record-breaking 794 Abstracts were submitted for the SVS 2024 Vascular Annual Meeting (VAM 2024). The abstracts were scored by the VAM Program Committee in early February 2024 and notice letters were sent out later that month. VAM 2024…
Carotid revascularization capable of improving mood in depressed patients with carotid atherosclerosis
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements irrespective of baseline depression. These findings were presented during the Plenary Session 1: William J. von…
VAM 2023: ‘What I wish I knew before retirement’ talk gives insight into adaptation and emeritus life
Reflecting on the positives and negatives of retirement, Peter Gloviczki, MD, from the Mayo Clinic, previously in Rochester, Minnesota, now in Scottsdale, Arizona, and editor-in-chief emeritus of the Journal of Vascular Surgery (JVS) regaled attendees of his “Lessons learned: What…
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid stenosis
A study set to be presented at VAM (14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularization (TCAR) are “not significantly affected” by prior head and neck radiation. Owing to substantially increased risks of…
More research needed but lithotripsy plus TCAR ‘an answer’ in certain carotid disease patients
Earlier this year, researchers debuted single-center experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularization (TCAR) into patients with traditionally prohibitive calcific disease. With a multicenter case series now further suggesting IVL’s utility, but also…
SVS reports on vascular surgeon concerns over pandemic health impacts
Vascular surgeons from across the country are reporting health impacts on some patients—particularly elderly ones—in quarantine, the Society for Vascular Surgery (SVS) reports. The SVS queried vascular surgeons regarding their concerns for patients’ health during the pandemic and shared its…
New meta-analysis finds ‘no observed difference’ in mortality between paclitaxel and uncoated device use in CLTI patients
February 2020 brings another paclitaxel device meta-analysis of randomized controlled trials in chronic limb-threatening ischemia (CLTI) patients. Krystal Dinh, BMed, of Westmead Hospital, Sydney, Australia, et al report online ahead of print that the risk of all-cause mortality after treatment with…
Drug-coated technology question aired during SAVS opening session
PALM BEACH, Fla.—Discussion of the drug-coated technology issue was piqued during the opening session of the Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 8–11) in Palm Beach, Florida. William P. Robinson III, MD, professor and chief in the…